Author

M. M. Sperry

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:Xenopus· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Organism:human· 1 Assay:metabolomics· 1

Frequent Co-Authors

D. E. Ingber· 2 shared M. Levin· 2 shared M. Super· 2 shared R. NovakiD· 2 shared A. Kuelker· 1 shared A. L. Dinis· 1 shared A. Sesay· 1 shared B. Charrez· 1 shared

Activity by Year

2021-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 40 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

D. E. Ingber

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Identification of pharmacological inducers of a reversible hypometabolic state for whole organ preservation

M. M. Sperry, B. Charrez, H. Fotowat, E. Gardner, K. Pilobello, Z. Izadifar, T. Lin, A. Kuelker, S. Kaki, M. Lewandowski, S. Lightbown, R. Martinez, S. Marquez, J. Moore, M. Plaza-Oliver, , D. E. Ingber

The paper identifies SNC80 as a drug that reversibly slows metabolism in Xenopus and demonstrates its cross-species applicability in human organs-on-chips and porcine organs.

eLife · Sep 24, 2024Peer-reviewedBioengineering

Enhancers of host immune tolerance to bacterial infection discovered using linked computational and experimental approaches

M. M. Sperry, R. Novak, V. Keshari, A. L. Dinis, M. J. Cartwright, D. M. Camacho, J.-F. Pare, M. Super, M. Levin, D. E. Ingber

The paper identifies host tolerance mechanisms to bacterial infection using a Xenopus model and multi-omics analysis, finding that metal chelators and HIF-1 agonists enhance survival.

bioRxiv · Sep 30, 2021Immunology